Tradestie Institutional Equity Comparison Engine

MIRM vs ELVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ELVN Overall Edge

ELVN Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enliven Therapeutics, Inc. Common Stock (ELVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MIRM trades at N/M Forward P/E with -21.6% operating margin (+39.6% YoY revenue) versus ELVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MIRM sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MIRM N/M vs ELVN N/M Fwd P/E
Growth & Margin Winner ELVN
Op Margin -21.6% vs 0.0% ยท YoY +39.6% vs +0.0%
Momentum & Technical Winner ELVN
1Y +34.2% vs +134.5% ยท 52W Pos 44% vs 69%
Options & Structure Winner ELVN
BREAKDOWN (9th %ile IV) vs CONSOLIDATION (5th %ile IV)
MIRM NASDAQ
Mirum Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$92.92
-1.14% 1D
Market Cap $6.1B
1M Return +15.94%
1Y Return +34.17%
Forward P/E N/M
Unified AI Score
38.1 / 100 SELL
Tech 8.0 Fund 37.0 Flow 71.0 Mom 40.0
ELVN NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap $3.6B
1M Return +27.38%
1Y Return +134.53%
Forward P/E N/M
Unified AI Score
36.2 / 100 SELL
Tech 15.0 Fund 44.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MIRM +34.17% ELVN +134.53% Spread: +100.36 pp (ELVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MIRM TTM Op. Margin: -21.6% ELVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MIRM vs ELVN. Trailing 12-month operating profitability (MIRM -21.6% vs ELVN 0.0%) and valuation multiples (MIRM N/M vs ELVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MIRM (4) vs ELVN (4)
Institutional Metric MIRM ELVN Criterion Row Winner
Market Capitalization Scale $6.1B $3.6B Larger Scale MIRM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +39.6% +0.0% Higher Growth MIRM
Operating Margin (TTM) Profitability -21.6% 0.0% Higher Margin ELVN
Net Profit Margin Profitability -134.8% 0.0% Higher Margin ELVN
Return on Equity (ROE) Capital Efficiency -760.0% -16.8% Higher ROE ELVN
52-Week Range Position Momentum 44% ($63โ€“$130) 69% ($15โ€“$62) Stronger Trend ELVN
Beta / 30D Volatility Risk Regime 1.02ฮฒ ยท 49% Vol 0.96ฮฒ ยท 60% Vol Lower Realized Risk MIRM
Unified Institutional Score Composite Signal 38.1 / 100 (SELL) 36.2 / 100 (SELL) Higher Composite MIRM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MIRM vs ELVN Buy Guide
MIRM BREAKDOWN
92d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live MIRM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ELVN CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ELVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MIRM nor ELVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.